NICA — Nanologica AB (publ) Income Statement
0.000.00%
Last trade - 00:00
- SEK202.94m
- SEK181.47m
- SEK1.44m
R2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | SAS | SAS | SAS | SAS | SAS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 9.23 | 16.1 | 12.9 | 1.55 | 1.44 |
Cost of Revenue | |||||
Gross Profit | 7.66 | 15 | 4.92 | 3.23 | -0.076 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 29.3 | 35.7 | 53.6 | 52.4 | 71.4 |
Operating Profit | -20.1 | -19.6 | -40.7 | -50.9 | -70 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -21.1 | -22.2 | -44.8 | -55.2 | -75.2 |
Net Income After Taxes | -21.1 | -22.2 | -44.8 | -55.2 | -75.2 |
Net Income Before Extraordinary Items | |||||
Net Income | -21.1 | -22.2 | -44.8 | -55.2 | -75.2 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -21.1 | -22.2 | -44.8 | -55.2 | -75.2 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -1.23 | -0.917 | -1.58 | -1.8 | -1.78 |
Dividends per Share |